Nurix Therapeutics treatment of Waldenstrom macroglobulinemia gets orphan status
Nurix Therapeutics (NRIX)’ treatment of Waldenstrom macroglobulinemia was granted FDA orphan designation, according to a post on the agency’s ...
Zacks Investment Research on MSN19h
ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates
ProQR (PRQR) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.08 per share a year ago. These figures are adjusted ...
The Manila Times12h
Canterbury Park Holding Corporation Announces Quarterly Cash Dividend
Canterbury Park Holding Corporation ("Canterbury” or the "Company”) (NASDAQ: CPHC), today announced that the Company's Board of Directors, pursuant to its dividend policy, approved a quarterly cash ...